Advertisement
Advertisement

HCA

HCA logo

HCA Healthcare, Inc.

493.66
USD
Sponsored
-5.99
-1.20%
Mar 20, 15:59 UTC -4
Closed
exchange

After-Market

495.39

+1.73
+0.35%

HCA Earnings Reports

Positive Surprise Ratio

HCA beat 27 of 40 last estimates.

68%

Next Report

Date of Next Report
Apr 23, 2026
Estimate for Q1 26 (Revenue/ EPS)
$19.28B
/
$7.24
Implied change from Q4 25 (Revenue/ EPS)
-1.21%
/
-11.06%
Implied change from Q1 25 (Revenue/ EPS)
+5.22%
/
+12.25%

HCA Healthcare, Inc. earnings per share and revenue

On Jan 27, 2026, HCA reported earnings of 8.14 USD per share (EPS) for Q4 25, beating the estimate of 7.53 USD, resulting in a 8.05% surprise. Revenue reached 19.51 billion, compared to an expected 19.88 billion, with a -1.84% difference. The market reacted with a +7.08% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 17 analysts forecast an EPS of 7.24 USD, with revenue projected to reach 19.28 billion USD, implying an decrease of -11.06% EPS, and decrease of -1.21% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
HealthEquity, Inc
Report Date
Mar 17, 2026 For Q4 26
Estimate
$0.90
Actual
$0.95
Surprise
+4.51%
logo
Sonida Senior Living, Inc.
Report Date
Mar 11, 2026 For Q4 25
Estimate
-$1.25
Actual
-$1.29
Surprise
-2.41%
logo
Auna S.A.
Report Date
Mar 10, 2026 For Q4 25
Estimate
-
Actual
$1.81
Surprise
-
logo
The Oncology Institute, Inc. Common Stock
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.09
Actual
-$0.06
Surprise
+33.99%
logo
Shoulder Innovations, Inc.
Report Date
Mar 10, 2026 For Q4 25
Estimate
-$0.33
Actual
-$0.38
Surprise
-14.49%
logo
LifeMD, Inc. Common Stock
Report Date
Mar 09, 2026 For Q4 25
Estimate
-$0.03
Actual
-$0.04
Surprise
-17.65%
logo
The Beauty Health Company Class A Common Stock
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.06
Surprise
-14.29%
logo
Sera Prognostics, Inc. Class A Common Stock
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$0.19
Actual
-$0.16
Surprise
+17.44%
logo
DocGo Inc. Common Stock
Report Date
Mar 16, 2026 For Q4 25
Estimate
-$0.13
Actual
-$0.53
Surprise
-294.64%
FAQ
For Q4 2025, HCA Healthcare, Inc. reported EPS of $8.14, beating estimates by 8.05%, and revenue of $19.51B, -1.84% below expectations.
The stock price moved up 7.08%, changed from $472.38 before the earnings release to $505.84 the day after.
The next earning report is scheduled for Apr 23, 2026.
Based on 17 analysts, HCA Healthcare, Inc. is expected to report EPS of $7.24 and revenue of $19.28B for Q1 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement